DOCN enters the week after one of the most violent re-ratings in cloud infrastructure this year — a 48% single-day earnings surge on May 5 that sent the stock from the low $80s to the $150s — and the more interesting question now isn't what happened, but who is still selling into the strength.
The dominant story in the register is Access Industries, the 10%-plus controlling holder. On May 11 and May 13 alone it sold more than 3.4 million shares, generating roughly $493 million in proceeds at prices around $150–161. Combined with smaller disposals, the 90-day net sell figure across all insiders clears $566 million in value. CFO Matt Steinfort also trimmed 25,000 shares at $152.50 on May 15. This is not routine diversification — a controlling shareholder offloading that volume at new highs is a material signal that the people with the most information about this business are treating the post-earnings pop as an exit window. Access still holds around 21% of shares outstanding following the sales, but the pace and size of the drawdown warrants attention.
The Street sprinted to reprice after the print. Goldman Sachs lifted its target from $78 to $179, maintaining Buy. Morgan Stanley moved from $75 to $175, keeping Overweight. Barclays raised from $105 to $183, also Overweight. Citigroup went from $115 to $180 with a Buy. These are not incremental adjustments — they reflect analysts catching up to a thesis shift, centred on the Character.ai win, AI inferencing growth, and the Inference Cloud Platform launch. The mean target now sits at $177, around 18% above the current price of $150. UBS is the holdout, twice raising its target (to $160 and then $175) while keeping its Neutral rating — a reminder that not everyone is fully bought in. The bull case rests on DigitalOcean moving upmarket into enterprise AI workloads. The bear case is equally concrete: long-term lease obligations, negative projected cash flows in 2027, and the structural difficulty of scaling go-to-market against hyperscalers with far deeper distribution.
Valuation has been pulled along for the ride. The P/E multiple has expanded 32 points over the past 30 days to roughly 107x. EV/EBITDA has compressed slightly to about 32x as estimates have been revised up, but the price-to-book has fallen by nearly 35 points over the same period as the share count and balance sheet picture changed. EPS momentum over 30 days ranks in the 93rd percentile — the recent beat was that large — but 90-day momentum drops to just the 8th percentile, pointing to how weak the set-up was before May 5. Factor scores elsewhere are modest: the short score rank sits in the 15th percentile, and the DTC rank at the 17th.
Short interest has been retreating from its peak. The float share at risk fell from roughly 14% in mid-to-late April to 11.4% now — a 21% decline in borrowed shares over the past month. The week's picture is more mixed: shorts added back around 320,000 shares day-on-day on May 19, but the weekly trend remains lower. Cost to borrow is ticking up — about 20% higher week-on-week to 0.49% — but that remains a trivially low absolute level for a name with this much attention. Borrow availability is loose at 314%, more than three times the shares currently short, which means there is no mechanical squeeze pressure in the lending market. The ORTEX short score of 57 has eased from the 60+ readings recorded in early May, consistent with a partial short cover following the earnings move. Options tell a similarly relaxed story: the put/call ratio at 0.54 is slightly below its 20-day average of 0.58 and well inside the year's range of 0.31–1.00. There is no defensiveness being priced into options right now.
Among correlated peers, BLZE gained nearly 7% on the week while AKAM fell 5.5% and NET rose 10.7%. The dispersion across cloud infrastructure names suggests idiosyncratic factors are dominating, rather than a sector-wide bid. DOCN itself is down 3.7% on the week — a modest give-back after the May 5 explosion — while the Access Industries selling program was active. The next scheduled earnings event date is absent from the calendar, making the ongoing insider disposition cadence and whether sell-side targets continue to drift higher the two cleanest variables to track in coming sessions.
See the live data behind this article on ORTEX.
Open DOCN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
